Clinical trials recruiting for Ulcerative colitis
288
Recruiting trials
44
US states with sites
56
Countries
11%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Vedolizumab | 7 |
| Infliximab | 5 |
| Mesalamine | 5 |
| Mirikizumab | 5 |
| Upadacitinib | 5 |
| Etrasimod | 4 |
| Guselkumab | 4 |
| Afimkibart | 3 |
| Ozanimod | 3 |
| Ustekinumab | 3 |
| Vedolizumab IV | 3 |
| Vedolizumab SC | 3 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 44 |
| Texas | 39 |
| Florida | 38 |
| New York | 37 |
| Ohio | 29 |
| Illinois | 28 |
| North Carolina | 27 |
| Arizona | 23 |
| Michigan | 23 |
| Washington | 23 |
| Colorado | 20 |
| Pennsylvania | 20 |
Top cities
New York, New York 29Miami, Florida 24Houston, Texas 21Orlando, Florida 19San Antonio, Texas 19Chicago, Illinois 16Colorado Springs, Colorado 15Kissimmee, Florida 15Los Angeles, California 15Tacoma, Washington 15
Self-screener
Recruiting trials
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
- A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
- A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
- A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
- A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
- A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
- A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis
- A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis
- A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- A Study for HSK47388 in Participants With Ulcerative Colitis
- A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
- A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
- A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
- A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
- A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
- A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
- A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
- A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
- AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
- AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
- Alpha Lipoic Acid in Ulcerative Colitis
- An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
- An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases
- Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
- Argentine Registry of Crohn's Disease and Ulcerative Colitis
- Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
- Association Between LRG and Histologic Remission in Ulcerative Colitis
- Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
- BOOM-IBD2 Pivotal Clinical Trial
- Beneficial Effect of Silymarin in Ulcerative Colitis
- Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
- CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease
- CEDUR - German IBD Registry
- COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
- Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
- Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.
- Combination of Diet and Oral Budesonide for Ulcerative Colitis
- Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
- Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study
- Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis
- Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis
- Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
- Confirmatory Clinical Study in Active Ulcerative Colitis
- Critical State of "Remission-Recurrence" of Ulcerative Colitis
- DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
- De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
- Desloratadine in Patients With Ulcerative Colitis
- Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
- Diet Intervention Treatment for Active Ulcerative Colitis
- Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis
- Digestive Biobank for Exploring Microbiota-host Interactions
Related conditions
Trials recruiting for Ulcerative colitis often also study these conditions. Each links to its own recruiting-trial list.
Crohn's disease 328Inflammatory bowel disease 63Colitis Ulcerative 33Inflammatory Bowel Disease (IBD) 29Psoriasis 233Inflammatory Bowel Disease 15Ulcerative Colitis (Disorder) 9IBD 13Rheumatoid arthritis 314IBD (Inflammatory Bowel Disease) 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Ulcerative colitis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.